Genetics of inherited cardiomyopathy.
暂无分享,去创建一个
[1] J. Svendsen,et al. Mutation analysis and evaluation of the cardiac localization of TMEM43 in arrhythmogenic right ventricular cardiomyopathy , 2011, Clinical genetics.
[2] P. Elliott,et al. Familial Evaluation in Arrhythmogenic Right Ventricular Cardiomyopathy: Impact of Genetics and Revised Task Force Criteria , 2011, Circulation.
[3] R. Hauer,et al. Distinguishing arrhythmogenic right ventricular cardiomyopathy/dysplasia-associated mutations from background genetic noise. , 2011, Journal of the American College of Cardiology.
[4] J. Vockley,et al. Novel mutation in MYH7 gene associated with distal myopathy and cardiomyopathy , 2011, Neuromuscular Disorders.
[5] H. Calkins. Use of mouse models to evaluate novel therapeutic approaches to treatment of arrhythmogenic right ventricular cardiomyopathy the future is now. , 2011, Journal of the American College of Cardiology.
[6] S. Day,et al. Psychological Issues in Genetic Testing for Inherited Cardiovascular Diseases , 2011, Circulation. Cardiovascular genetics.
[7] Ray B. Jones,et al. Can We Make Assumptions About the Psychosocial Impact of Living as a Carrier, Based on Studies Assessing the Effects of Carrier Testing? , 2011, Journal of Genetic Counseling.
[8] A. Keren,et al. Genetic counselling and testing in cardiomyopathies: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. , 2010, European heart journal.
[9] Ana Morales,et al. Clinical and genetic issues in dilated cardiomyopathy: A review for genetics professionals , 2010, Genetics in Medicine.
[10] K. Davidson,et al. Depressive symptoms and all-cause mortality in unstable angina pectoris (from the Coronary Psychosocial Evaluation Studies [COPES]). , 2010, The American journal of cardiology.
[11] S. Colan,et al. The pediatric cardiomyopathy registry and heart failure: key results from the first 15 years. , 2010, Heart failure clinics.
[12] A. Henning,et al. Metabolic Modulator Perhexiline Corrects Energy Deficiency and Improves Exercise Capacity in Symptomatic Hypertrophic Cardiomyopathy , 2010, Circulation.
[13] W. McKenna,et al. The Cardiac Desmosome and Arrhythmogenic Cardiomyopathies: From Gene to Disease , 2010, Circulation research.
[14] R. Porcher,et al. Prevalence and spectrum of mutations in a cohort of 192 unrelated patients with hypertrophic cardiomyopathy. , 2010, European journal of medical genetics.
[15] L. Salberg,et al. Emotional Stress Triggers Symptoms in Hypertrophic Cardiomyopathy: A Survey of the Hypertrophic Cardiomyopathy Association , 2010, Pacing and clinical electrophysiology : PACE.
[16] J. Chambers,et al. Mutational Heterogeneity, Modifier Genes, and Environmental Influences Contribute to Phenotypic Diversity of Arrhythmogenic Cardiomyopathy , 2010, Circulation. Cardiovascular genetics.
[17] M. Sheppard,et al. Prevalence of Desmosomal Protein Gene Mutations in Patients With Dilated Cardiomyopathy , 2010, Circulation. Cardiovascular genetics.
[18] P. Thompson,et al. Exercise Prescription and Primary Prevention of Cardiovascular Disease , 2010, Circulation.
[19] N. Norton,et al. Identification of Novel Mutations in RBM20 in Patients with Dilated Cardiomyopathy , 2010, Clinical and translational science.
[20] J. Seidman,et al. Narrative Review: Harnessing Molecular Genetics for the Diagnosis and Management of Hypertrophic Cardiomyopathy , 2010, Annals of Internal Medicine.
[21] J. Seidman,et al. Harnessing Molecular Genetics for the Diagnosis and Management of Hypertrophic Cardiomyopathy , 2010 .
[22] P. Nihoyannopoulos,et al. Left ventricular non-compaction: genetic heterogeneity, diagnosis and clinical course. , 2010, International journal of cardiology.
[23] W. Chung,et al. Short Communication: The Cardiac Myosin Binding Protein C Arg502Trp Mutation: A Common Cause of Hypertrophic Cardiomyopathy , 2010, Circulation research.
[24] Michael J Ackerman,et al. Clinical features and outcome of hypertrophic cardiomyopathy associated with triple sarcomere protein gene mutations. , 2010, Journal of the American College of Cardiology.
[25] H. Watkins,et al. DNA testing for hypertrophic cardiomyopathy: a cost-effectiveness model. , 2010, European heart journal.
[26] P. Syrris,et al. Genetics of restrictive cardiomyopathy. , 2010, Heart failure clinics.
[27] Wojciech Zareba,et al. Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: Proposed Modification of the Task Force Criteria , 2010, European heart journal.
[28] V. Ruppert,et al. PREVALENCE OF DIFFERENT ETIOLOGIES IN DILATED CARDIOMYOPATHY , 2010 .
[29] D. Mozaffarian,et al. Defining and Setting National Goals for Cardiovascular Health Promotion and Disease Reduction: The American Heart Association's Strategic Impact Goal Through 2020 and Beyond , 2010, Circulation.
[30] H. Okayama,et al. Pharmacogenetic Interactions Between Angiotensin-Converting Enzyme Insertion/Deletion Polymorphism and Response to Cibenzoline in Patients With Hypertrophic Obstructive Cardiomyopathy , 2010, Journal of cardiovascular pharmacology.
[31] J. Tardiff. Tropomyosin and dilated cardiomyopathy: revenge of the actinomyosin "gatekeeper". , 2010, Journal of the American College of Cardiology.
[32] Birgit Funke,et al. Familial dilated cardiomyopathy caused by an alpha-tropomyosin mutation: the distinctive natural history of sarcomeric dilated cardiomyopathy. , 2010, Journal of the American College of Cardiology.
[33] John C Chambers,et al. Arrhythmogenic cardiomyopathy: etiology, diagnosis, and treatment. , 2010, Annual review of medicine.
[34] M. P. van den Berg,et al. A genetic variants database for arrhythmogenic right ventricular dysplasia/cardiomyopathy , 2009, Human mutation.
[35] A. Moorman,et al. Myocyte necrosis underlies progressive myocardial dystrophy in mouse dsg2-related arrhythmogenic right ventricular cardiomyopathy , 2009, The Journal of experimental medicine.
[36] J. Towbin,et al. Diagnostic, prognostic, and therapeutic implications of genetic testing for hypertrophic cardiomyopathy. , 2009, Journal of the American College of Cardiology.
[37] D. Corrado,et al. Arrhythmogenic right ventricular cardiomyopathy: an update , 2009, Heart.
[38] B. Maron,et al. Sudden Deaths in Young Competitive Athletes: Analysis of 1866 Deaths in the United States, 1980–2006 , 2009, Circulation.
[39] L. Hougs,et al. Diagnostic yield, interpretation, and clinical utility of mutation screening of sarcomere encoding genes in Danish hypertrophic cardiomyopathy patients and relatives , 2009, Human mutation.
[40] S. Shete,et al. Identifying Modifier Loci in Existing Genome Scan Data , 2008, Annals of human genetics.
[41] B. Rozell,et al. Reversible phenotype in a mouse model of Hutchinson–Gilford progeria syndrome , 2008, Journal of Medical Genetics.
[42] G. Dorn,et al. The Ser96Ala variant in histidine-rich calcium-binding protein is associated with life-threatening ventricular arrhythmias in idiopathic dilated cardiomyopathy , 2008, European heart journal.
[43] P. Rahko,et al. Lamin A/C mutation analysis in a cohort of 324 unrelated patients with idiopathic or familial dilated cardiomyopathy. , 2008, American heart journal.
[44] F. Berger,et al. Mutations in Sarcomere Protein Genes in Left Ventricular Noncompaction , 2008, Circulation.
[45] Rachael,et al. Myofilament protein gene mutation screening and outcome of patients with hypertrophic cardiomyopathy. , 2008, Mayo Clinic proceedings.
[46] N. Sebire,et al. Idiopathic restrictive cardiomyopathy in children is caused by mutations in cardiac sarcomere protein genes , 2008, Heart.
[47] Sean Connors,et al. Arrhythmogenic right ventricular cardiomyopathy type 5 is a fully penetrant, lethal arrhythmic disorder caused by a missense mutation in the TMEM43 gene. , 2008, American journal of human genetics.
[48] S. Suvarna,et al. Dilated cardiomyopathy and sudden death in a teenager with palmar-plantar keratosis (occult Carvajal syndrome). , 2008, Journal of forensic and legal medicine.
[49] F. Bayrak,et al. Genetic analysis of the Irx4 gene in hypertrophic cardiomyopathy. , 2008, Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir.
[50] D. Bers. Calcium cycling and signaling in cardiac myocytes. , 2008, Annual review of physiology.
[51] P. J. Griffiths,et al. Dilated and Hypertrophic Cardiomyopathy Mutations in Troponin and &agr;-Tropomyosin Have Opposing Effects on the Calcium Affinity of Cardiac Thin Filaments , 2007, Circulation research.
[52] P. Elliott,et al. Diagnosis of left-ventricular non-compaction in patients with left-ventricular systolic dysfunction: time for a reappraisal of diagnostic criteria? , 2007, European heart journal.
[53] Eloisa Arbustini,et al. Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. , 2007, European heart journal.
[54] R. Sandhu,et al. Prevalence and Characteristics of Left Ventricular Noncompaction in a Community Hospital Cohort of Patients with Systolic Dysfunction , 2007, Echocardiography.
[55] A. Marian. Phenotypic plasticity of sarcomeric protein mutations. , 2007, Journal of the American College of Cardiology.
[56] P. Elliott,et al. Prevalence, clinical significance, and genetic basis of hypertrophic cardiomyopathy with restrictive phenotype. , 2007, Journal of the American College of Cardiology.
[57] A. Perrot,et al. Letter by Geier et al regarding article, "Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction". , 2007, Circulation.
[58] M. Link,et al. Response to Letter Regarding Article, “Hypertrophic Cardiomyopathy Is Predominantly a Disease of Left Ventricular Outflow Tract Obstruction” , 2007 .
[59] C. Patterson. Faculty Opinions recommendation of Exercise reverses preamyloid oligomer and prolongs survival in alphaB-crystallin-based desmin-related cardiomyopathy. , 2007 .
[60] R. Kayed,et al. Exercise reverses preamyloid oligomer and prolongs survival in αB-crystallin-based desmin-related cardiomyopathy , 2007, Proceedings of the National Academy of Sciences.
[61] Petros Syrris,et al. Clinical and Genetic Characterization of Families With Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Provides Novel Insights Into Patterns of Disease Expression , 2007, Circulation.
[62] B. Funke,et al. Dilated cardiomyopathy , 2007, Archives of Disease in Childhood.
[63] C. Long,et al. Prevalence of Desmin Mutations in Dilated Cardiomyopathy , 2007, Circulation.
[64] P. Elliott,et al. Prospective Familial Assessment in Dilated Cardiomyopathy: Cardiac Autoantibodies Predict Disease Development in Asymptomatic Relatives , 2006, Circulation.
[65] O. Ozeke,et al. Clinical features of isolated ventricular noncompaction in adults long-term clinical course, echocardiographic properties, and predictors of left ventricular failure. , 2006, Journal of cardiac failure.
[66] M. Link,et al. Hypertrophic Cardiomyopathy Is Predominantly a Disease of Left Ventricular Outflow Tract Obstruction , 2006, Circulation.
[67] P. Syrris,et al. Arrhythmogenic right ventricular dysplasia/cardiomyopathy associated with mutations in the desmosomal gene desmocollin-2. , 2006, American journal of human genetics.
[68] R. Schwinger,et al. Alterations of Tension-dependent ATP Utilization in a Transgenic Rat Model of Hypertrophic Cardiomyopathy* , 2006, Journal of Biological Chemistry.
[69] S. Ellard,et al. The laminopathies: a clinical review , 2006, Clinical genetics.
[70] M. Bergo,et al. A farnesyltransferase inhibitor improves disease phenotypes in mice with a Hutchinson-Gilford progeria syndrome mutation. , 2006, The Journal of clinical investigation.
[71] W. Manning,et al. Prevalence, Clinical Profile, and Significance of Left Ventricular Remodeling in the End-Stage Phase of Hypertrophic Cardiomyopathy , 2006, Circulation.
[72] Michael D. Schneider,et al. Suppression of canonical Wnt/beta-catenin signaling by nuclear plakoglobin recapitulates phenotype of arrhythmogenic right ventricular cardiomyopathy. , 2006, The Journal of clinical investigation.
[73] Barry J Maron,et al. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interd , 2006, Circulation.
[74] Stephen G Young,et al. A Protein Farnesyltransferase Inhibitor Ameliorates Disease in a Mouse Model of Progeria , 2006, Science.
[75] G. Danieli,et al. Mutations in Desmoglein-2 Gene Are Associated With Arrhythmogenic Right Ventricular Cardiomyopathy , 2006, Circulation.
[76] P. Elliott,et al. Clinical Expression of Plakophilin-2 Mutations in Familial Arrhythmogenic Right Ventricular Cardiomyopathy , 2006, Circulation.
[77] Erik G. Ellsworth,et al. Gene-specific modifying effects of pro-LVH polymorphisms involving the renin-angiotensin-aldosterone system among 389 unrelated patients with hypertrophic cardiomyopathy. , 2005, European heart journal.
[78] B. Bruneau,et al. The Homeodomain Transcription Factor Irx5 Establishes the Mouse Cardiac Ventricular Repolarization Gradient , 2005, Cell.
[79] Aldrin V Gomes,et al. Mutations in Human Cardiac Troponin I That Are Associated with Restrictive Cardiomyopathy Affect Basal ATPase Activity and the Calcium Sensitivity of Force Development* , 2005, Journal of Biological Chemistry.
[80] J. Potter,et al. Sarcomeric Protein Mutations in Dilated Cardiomyopathy , 2005, Heart Failure Reviews.
[81] Christine E Seidman,et al. The genetic basis for cardiac remodeling. , 2005, Annual review of genomics and human genetics.
[82] P. Syrris,et al. Genetics of Right Ventricular Cardiomyopathy , 2005, Journal of cardiovascular electrophysiology.
[83] P. Elliott,et al. Echocardiographic Evaluation in Asymptomatic Relatives of Patients with Dilated Cardiomyopathy Reveals Preclinical Disease , 2005, Annals of Internal Medicine.
[84] A. Tajik,et al. Yield of genetic testing in hypertrophic cardiomyopathy. , 2005, Mayo Clinic proceedings.
[85] S. Russell,et al. Arrhythmogenic Right Ventricular Dysplasia: A United States Experience , 2005, Circulation.
[86] M. Komajda,et al. Mutation screening in dilated cardiomyopathy: prominent role of the beta myosin heavy chain gene. , 2005, European heart journal.
[87] H. Bécane,et al. Effect of perindopril on the onset and progression of left ventricular dysfunction in Duchenne muscular dystrophy. , 2005, Journal of the American College of Cardiology.
[88] G. Danieli,et al. Regulatory mutations in transforming growth factor-beta3 gene cause arrhythmogenic right ventricular cardiomyopathy type 1. , 2005, Cardiovascular research.
[89] Jeffrey L. Anderson,et al. Sodium channel mutations and susceptibility to heart failure and atrial fibrillation. , 2005, JAMA.
[90] Masahiko Hoshijima,et al. Tcap gene mutations in hypertrophic cardiomyopathy and dilated cardiomyopathy. , 2004, Journal of the American College of Cardiology.
[91] S. Peters,et al. Prevalence of right ventricular dysplasia-cardiomyopathy in a non-referral hospital. , 2004, International journal of cardiology.
[92] H. Watkins,et al. Severe disease expression of cardiac troponin C and T mutations in patients with idiopathic dilated cardiomyopathy. , 2004, Journal of the American College of Cardiology.
[93] D. Paulin,et al. Desmin: a major intermediate filament protein essential for the structural integrity and function of muscle. , 2004, Experimental cell research.
[94] Walter Birchmeier,et al. Mutations in the desmosomal protein plakophilin-2 are common in arrhythmogenic right ventricular cardiomyopathy , 2004, Nature Genetics.
[95] L. Mestroni,et al. SCN5A Mutation Associated With Dilated Cardiomyopathy, Conduction Disorder, and Arrhythmia , 2004, Circulation.
[96] I. Desguerre,et al. Nuclear envelope alterations in fibroblasts from patients with muscular dystrophy, cardiomyopathy, and partial lipodystrophy carrying lamin A/C gene mutations , 2004, Muscle & nerve.
[97] P. Rizzon,et al. Association of β-adrenergic receptor polymorphisms and progression to heart failure in patients with idiopathic dilated cardiomyopathy , 2004 .
[98] J. Saffitz,et al. Desmin-related cardiomyopathy in transgenic mice: a cardiac amyloidosis. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[99] N. Protonotarios,et al. Naxos disease and Carvajal syndrome: cardiocutaneous disorders that highlight the pathogenesis and broaden the spectrum of arrhythmogenic right ventricular cardiomyopathy. , 2004, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.
[100] L. Monserrat,et al. Familial dilated cardiomyopathy and isolated left ventricular noncompaction associated with lamin A/C gene mutations. , 2004, The American journal of cardiology.
[101] M. Delmar. The intercalated disk as a single functional unit. , 2004, Heart rhythm.
[102] J. Potter,et al. Familial Hypertrophic Cardiomyopathy Mutations from Different Functional Regions of Troponin T Result in Different Effects on the pH and Ca2+ Sensitivity of Cardiac Muscle Contraction* , 2004, Journal of Biological Chemistry.
[103] J. Mogensen,et al. Novel mutation in cardiac troponin I in recessive idiopathic dilated cardiomyopathy , 2004, The Lancet.
[104] D. Malicier,et al. Circumstances of Death and Gross and Microscopic Observations in a Series of 200 Cases of Sudden Death Associated With Arrhythmogenic Right Ventricular Cardiomyopathy and/or Dysplasia , 2003, Circulation.
[105] G. Valle,et al. Mutations in Cypher/ZASP in patients with dilated cardiomyopathy and left ventricular non-compaction. , 2003, Journal of the American College of Cardiology.
[106] Maurizio Schiavon,et al. Does sports activity enhance the risk of sudden death in adolescents and young adults? , 2003, Journal of the American College of Cardiology.
[107] C. Tracy,et al. American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice G , 2003, European heart journal.
[108] R. Schwartz,et al. Mutations in the muscle LIM protein and alpha-actinin-2 genes in dilated cardiomyopathy and endocardial fibroelastosis. , 2003, Molecular genetics and metabolism.
[109] Ferhaan Ahmad,et al. Transgenic Mice Overexpressing Mutant PRKAG2 Define the Cause of Wolff-Parkinson-White Syndrome in Glycogen Storage Cardiomyopathy , 2003, Circulation.
[110] A. Blamire,et al. Hypertrophic cardiomyopathy due to sarcomeric gene mutations is characterized by impaired energy metabolism irrespective of the degree of hypertrophy. , 2003, Journal of the American College of Cardiology.
[111] M. Komajda,et al. Hypertrophic Cardiomyopathy: Distribution of Disease Genes, Spectrum of Mutations, and Implications for a Molecular Diagnosis Strategy , 2003, Circulation.
[112] P. Elliott,et al. Idiopathic restrictive cardiomyopathy is part of the clinical expression of cardiac troponin I mutations. , 2003, The Journal of clinical investigation.
[113] Iacopo Olivotto,et al. Maximum left ventricular thickness and risk of sudden death in patients with hypertrophic cardiomyopathy. , 2003, Journal of the American College of Cardiology.
[114] G. Danieli,et al. Mutation in human desmoplakin domain binding to plakoglobin causes a dominant form of arrhythmogenic right ventricular cardiomyopathy. , 2002, American journal of human genetics.
[115] M. S. Hamid,et al. Prospective evaluation of relatives for familial arrhythmogenic right ventricular cardiomyopathy/dysplasia reveals a need to broaden diagnostic criteria. , 2002, Journal of the American College of Cardiology.
[116] J. Towbin,et al. Mutations in the dystrophin gene are associated with sporadic dilated cardiomyopathy. , 2002, Molecular genetics and metabolism.
[117] D. Srivastava,et al. Bop encodes a muscle-restricted protein containing MYND and SET domains and is essential for cardiac differentiation and morphogenesis , 2002, Nature Genetics.
[118] F. Marcus,et al. Arrhythmogenic Right Ventricular Dysplasia Masquerading as Peripartum Cardiomyopathy with Atrial Flutter, Advanced Atrioventricular Block and Embolic Stroke , 2002, Cardiology.
[119] J. Seidman,et al. Constitutively active AMP kinase mutations cause glycogen storage disease mimicking hypertrophic cardiomyopathy. , 2002, The Journal of clinical investigation.
[120] M. Keating,et al. Metavinculin Mutations Alter Actin Interaction in Dilated Cardiomyopathy , 2002, Circulation.
[121] R. Brugada,et al. Novel Cardiac Troponin T Mutation as a Cause of Familial Dilated Cardiomyopathy , 2001, Circulation.
[122] S. Solomon,et al. Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy. , 2001, The New England journal of medicine.
[123] J. Towbin,et al. Novel Gene Mutations in Patients With Left Ventricular Noncompaction or Barth Syndrome , 2001, Circulation.
[124] D. Kass,et al. Cardiomyopathy in Irx4-Deficient Mice Is Preceded by Abnormal Ventricular Gene Expression , 2001, Molecular and Cellular Biology.
[125] D. Stephan,et al. Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2). , 2001, Human molecular genetics.
[126] P. Elliott,et al. Sudden death in hypertrophic cardiomyopathy: identification of high risk patients. , 2000, Journal of the American College of Cardiology.
[127] W J McKenna,et al. Hypertrophic cardiomyopathy: the interrelation of disarray, fibrosis, and small vessel disease , 2000, Heart.
[128] D. Kelsell,et al. Recessive mutation in desmoplakin disrupts desmoplakin-intermediate filament interactions and causes dilated cardiomyopathy, woolly hair and keratoderma. , 2000, Human molecular genetics.
[129] P. Kaufmann,et al. Long-term follow-up of 34 adults with isolated left ventricular noncompaction: a distinct cardiomyopathy with poor prognosis. , 2000, Journal of the American College of Cardiology.
[130] A. Crosby,et al. Identification of a deletion in plakoglobin in arrhythmogenic right ventricular cardiomyopathy with palmoplantar keratoderma and woolly hair (Naxos disease) , 2000, The Lancet.
[131] J B Seward,et al. Clinical profile and outcome of idiopathic restrictive cardiomyopathy. , 2000, Circulation.
[132] Neil E. Bowles,et al. The “Final Common Pathway” Hypothesis and Inherited Cardiovascular Disease The Role of Cytoskeletal Proteins in Dilated Cardiomyopathy , 2000, Herz.
[133] T. Negri,et al. Disruption of heart sarcoglycan complex and severe cardiomyopathy caused by β sarcoglycan mutations , 2000, Journal of medical genetics.
[134] W. Edwards,et al. Arrhythmogenic right ventricular dysplasia masquerading as dilated cardiomyopathy. , 1999, The American journal of cardiology.
[135] L. Mestroni,et al. Familial dilated cardiomyopathy: evidence for genetic and phenotypic heterogeneity. Heart Muscle Disease Study Group. , 1999, Journal of the American College of Cardiology.
[136] D. Corrado,et al. Cardiovascular causes of sudden death in young individuals including athletes. , 1999, Cardiology in review.
[137] Dimitrios Georgakopoulos,et al. The pathogenesis of familial hypertrophic cardiomyopathy: Early and evolving effects from an α-cardiac myosin heavy chain missense mutation , 1999, Nature Medicine.
[138] B. McCrindle,et al. Long-term outcome and prognostic determinants in children with hypertrophic cardiomyopathy. , 1998, Journal of the American College of Cardiology.
[139] D. Levy,et al. Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death. , 1998, Journal of the American College of Cardiology.
[140] S. Ratel,et al. Pathology of arrhythmogenic right ventricular cardiomyopathy/dysplasia--an autopsy study of 20 forensic cases. , 1998, Journal of forensic sciences.
[141] S. Thibodeau,et al. Actin mutations in dilated cardiomyopathy, a heritable form of heart failure. , 1998, Science.
[142] H Niimura,et al. Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy. , 1998, The New England journal of medicine.
[143] E. Maestrini,et al. A novel X-linked gene, G4.5. is responsible for Barth syndrome , 1996, Nature Genetics.
[144] J. Gardin,et al. Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. , 1995, Circulation.
[145] J. Seidman,et al. Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy. , 1995, The New England journal of medicine.
[146] A P Yoganathan,et al. Papillary muscle displacement causes systolic anterior motion of the mitral valve. Experimental validation and insights into the mechanism of subaortic obstruction. , 1995, Circulation.
[147] B. Maron,et al. Prevalence of hypertrophic cardiomyopathy in an outpatient population referred for echocardiographic study. , 1994, The American journal of cardiology.
[148] A. di Lenarda,et al. Restrictive left ventricular filling pattern in dilated cardiomyopathy assessed by doppler echocardiography: Clinical, echocardiographic and hemodynamic correlations and prognostic implications , 1993 .
[149] S. Yusuf,et al. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. , 1992, The New England journal of medicine.
[150] J. Seidman,et al. Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy. , 1992, The New England journal of medicine.
[151] J. Laragh,et al. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. , 1991, Annals of internal medicine.
[152] J. Seidman,et al. A molecular basis for familial hypertrophic cardiomyopathy: A β cardiac myosin heavy chain gene missense mutation , 1990, Cell.
[153] M. Elleder,et al. Cardiocyte storage and hypertrophy as a sole manifestation of Fabry's disease , 1990, Virchows Archiv A.
[154] S. Solomon,et al. Mapping a gene for familial hypertrophic cardiomyopathy to chromosome 14q1. , 1989, The New England journal of medicine.
[155] R. Bonow,et al. Occurrence and significance of progressive left ventricular wall thinning and relative cavity dilatation in hypertrophic cardiomyopathy. , 1987, The American journal of cardiology.
[156] Y. Eishi,et al. Glycogen storage disease confined to the heart with deficient activity of cardiac phosphorylase kinase: a new type of glycogen storage disease. , 1985, Human pathology.
[157] B. Dahms,et al. An X-linked recessive cardiomyopathy with abnormal mitochondria. , 1979, Pediatrics.
[158] J. Griffith,et al. Mechanism of left ventricular outlfow obstruction in patients with obstructive asymmetric septal hypertrophy (idiopathic hypertrophic subaortic stenosis). , 1975, The American journal of cardiology.
[159] A. Hill,et al. Open Access RESEARCH , 2010 .
[160] M. Penicka,et al. The effects of candesartan on left ventricular hypertrophy and function in nonobstructive hypertrophic cardiomyopathy: a pilot, randomized study. , 2009, The Journal of molecular diagnostics : JMD.
[161] M. Böhm,et al. Identification of mutational hot spots in LMNA encoding lamin A/C in patients with familial dilated cardiomyopathy , 2008, Basic Research in Cardiology.
[162] N. Maraldi,et al. Nuclear envelope proteins and chromatin arrangement: a pathogenic mechanism for laminopathies. , 2006, European journal of histochemistry : EJH.
[163] P. Rizzon,et al. Association of beta-adrenergic receptor polymorphisms and progression to heart failure in patients with idiopathic dilated cardiomyopathy. , 2004, The American journal of medicine.
[164] Matthew J. Tyska,et al. R403Q and L908V mutant β-cardiac myosin from patients with familial hypertrophic cardiomyopathy exhibit enhanced mechanical performance at the single molecule level , 2004, Journal of Muscle Research & Cell Motility.
[165] J. Schmitt,et al. The L-type calcium channel inhibitor diltiazem prevents cardiomyopathy in a mouse model. , 2002, The Journal of clinical investigation.
[166] A. Tajik,et al. Prevalence and Severity of “Benign” Mutations in the β-Myosin Heavy Chain, Cardiac Troponin T, and α-Tropomyosin Genes in Hypertrophic Cardiomyopathy , 2002, Circulation.
[167] K. Kinzler,et al. Small changes in expression affect predisposition to tumorigenesis , 2002, Nature Genetics.
[168] H. Katus,et al. Frequency and phenotypes of familial dilated cardiomyopathy. , 1998, Journal of the American College of Cardiology.
[169] W. Mckenna,et al. Familial dilated cardiomyopathy: cardiac abnormalities are common in asymptomatic relatives and may represent early disease. , 1998, Journal of the American College of Cardiology.
[170] T. Pearson,et al. The American College of Cardiology Evaluation of Preventive Therapeutics (ACCEPT) study: attainment of goals for comprehensive risk reduction in patients with coronary disease in the US , 1998 .